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Abstract 
Symptoms of psychotic diseases historically instilled fear and distrust in onlookers, who 
associated them with witchcraft, demonic spirits, and the devil. From Egyptian medicine to 
medieval witch hunts, psychotic diseases have been associated with the supernatural throughout 
history. Yet even with advancements in neuroscience and improvements in our understanding of 
mental illness, stigma surrounding mental health remains prevalent today. Schizophrenia is a 
psychiatric illness which has evaded a clinical definition until relatively recently; even now, the 
precise features that constitute a schizophrenic patient are open to dispute. This article explores 
the ancient history of mental health with a particular emphasis on psychosis, and also considers 
the changing attitudes and understanding of schizophrenia throughout the last century, leading 
to its clinical definition as a treatable condition. 
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Schizophrenia – From devilry 
to disease 
Introduction 
Schizophrenia is a neurological disorder 
manifested by a variety of symptoms 
including hallucinations, delusions, and 
often disorder of speech. However, it is a 
condition which has evaded a clinical 
definition until relatively recently.1 In the 
past, symptoms of psychosis have been 
attributed to the heart and paranormal 
entities, and it has been only in the last 150 
years that the various forms of 
schizophrenia have been characterised as a 
single mental condition, by Dr Emil 
Kraepelin.2 The symptoms of schizophrenia, 
particularly paranoid schizophrenia, have 
been described for thousands of years, 
including in Ancient Egyptian medicine, 
Hindu culture, Ancient Greece and China, 
and have been the source of much 
persecution and adversity for those with the 
disease.3 By highlighting possible references 
to schizophrenia in history, a clearer view of 
not only the changes in medical definitions 
of psychosis, but also the changes in public 
opinion of those considered psychotic, may 
be formulated. 
Ancient medicine 
Some of the oldest medical texts originate 
from Ancient Egypt, and a closer analysis 
provides an insight into the attitudes 
towards mental diseases of that time. The 
Papyrus Ebers, a scroll written around 1500 
BC, contains references to mental 
conditions with associated diagnoses. 
However, it appears that the academics of 
that time assumed the heart and mind to be 
of the same entity: “When the Heart is 
miserable and is beside itself, behold it is the 
Breath of the heb-xer Priest”.4 The Ancient 
Egyptians therefore diagnosed most 
conditions as diseases of the heart, 
occasionally attributing particular conditions 
on the invasion of demons, a theme that 
was common throughout many ancient 
medical texts.3 Apart from containing 
references to some mental disorders, such as 
depression, the Papyrus Ebers do not to 
contain any direct descriptions of 
schizophrenia, contrary to what Theocharis 
Kyziridis argues in his Notes on the History of 
Schizophrenia.3 Nevertheless, it is worth citing 
these ancient papyri as some of the first 
recorded references to disorders of the 
mind.  
Mental illness and schizophrenia-like 
conditions appear in ancient Hindu culture, 
with symptoms being mentioned in many 
texts of that time, including the Atharva 
Veda.5 It was believed that good health was 
maintained through the interactions of 
“Buthas” and “Dosas”, and that if these two 
entities were unbalanced, insanity may 
result.3 The Atharva Veda contains a 
multitude of hymns to cure ill health, some 
of which were used to cure “possession by 
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demons of disease”. One particular extract 
makes reference to someone who “has been 
maddened by the sin of the gods, or been 
robbed of sense by the Rakshas” – the 
stereotypes of madness are often 
synonymous with the symptoms of 
schizophrenia. Therefore, it could be argued 
that the disease was present in this ancient 
population. This text also highlights the 
recurring attitude that such a condition must 
be caused by devilry or a sinister entity.5  
Much like the Ancient Egyptian medicine 
500 years before, Chinese medicine revolved 
around the concept that the heart was the 
centre of the mind and spirit, as depicted in 
The Yellow Emperor’s Classic of Internal Medicine: 
“The heart controls the spirit, the spleen 
controls ideas”. Symptoms of insanity and 
madness were therefore associated with 
diseases infecting the heart, with the cause 
being “evil influences” or an imbalance 
between “Yin” and “Yang”.6 
In 400 BC, Hippocrates described mental 
conditions as problems of the brain and was 
one of the first to record these diseases as 
tangible, medical conditions: “… from the 
brain only, arise our pleasures, joys, laughter 
and jests, as well as our sorrows, pains, 
griefs and tears. […] Madness comes from 
its moistness.”7 Although ground breaking 
in his time, the work of Hippocrates was 
often met with scepticism and 
misunderstanding from the public.7 
Ancient diagnoses of diseases were 
summarized in a medical handbook, written 
by Aretaeus in the second century AD. 
Symptoms of schizophrenia were depicted 
as conditions of “mania” and “melancholy”, 
with treatment methods revolving around a 
theory of humoral pathology and a 
rectification of imbalances of the body.3 
Humoral pathology was also practised by 
Galen, who attributed mental disorders to a 
disease of the brain and welcomed the 
possible involvement of other organs, 
marking an improvement in the approach to 
mental disorders and setting the foundation 
for further advancements in the field that 
would later become psychiatry.8  
The Middle Ages 
The writings of Aretaeus and Galen 
developed the notion of mind–body unity. 
However, the concept of Galenism that 
predominated medical thinking throughout 
the Middle Ages, brought to Europe 
through Arabic writings, was often at odds 
with cultural beliefs and myths of the time, 
and instead religious superstition dominated 
the field of mental health.9,10 
Despite the founding of Europe’s first 
“asylum” in the 15th century, the general 
public viewed hallucinations and delusions 
as justification of demonic possession and 
witchcraft.11 Upon confession, “witches” 
were made to recount their seduction by the 
devil, which often occurred at times when 
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they were psychologically vulnerable. These 
alleged conversations with Satan are similar 
to auditory hallucinations experienced by 
paranoid schizophrenics, making it possible 
that many persecuted witches may have 
been sufferers of the disease.11,12 In the 15th 
century, the practice of exorcism was 
developed as a treatment for demonic 
possession. Although theories and 
explanations of mental disorders have 
radically changed in the last 600 years, 
exorcisms are still performed by various 
extremists and cults as a cure for what is 
now viewed as a treatable mental 
condition.12  
The 16th century was an age of reformation, 
featuring radical cultural changes throughout 
Europe. None was more significant than the 
unshackling of medical science from the 
religious and cultural superstitions of the 
time. With the end of the Middle Ages also 
came the demise of an era of witch hunts 
and exorcisms. However, the foundations of 
fear towards mental disease had been laid 
and would prove more difficult to uproot.9  
Emil Kraepelin and Eugen Bleuler 
Two of the most notable psychiatrists of 
19th century Europe, Emil Kraepelin and 
Eugen Bleuler, were instrumental in the 
development of modern definitions of 
schizophrenia. Kraepelin combined the 
previously defined disease entities of 
hebephrenia, catatonia, and his own 
paranoid form into one condition when he 
described “dementia praecox”. In his text 
Manic-Depressive Insanity and Paranoia, 
Kraepelin describes many symptoms 
consistent with modern concepts of 
schizophrenia.2,13,14 However, the term 
“dementia praecox” was later considered 
inaccurate by Bleuler, as the disease was 
based on an end stage of dementia, and 
suggested inappropriate treatment 
methods.15 As a result, in 1919, Dr Elmer 
Ernest Southard proposed the term 
“dementia praecox” to be dropped in favour 
of Bleuler’s term “schizophrenia”, which he 
had coined 8 years earlier.3,16 The word 
“schizophrenia” is derived from the Greek 
words schizo and phren, to mean “split mind”. 
Bleuler originally intended this to depict the 
disjointed and often confused thoughts of 
sufferers of the disease, however, this has 
also been the source of many 
misconceptions surrounding schizophrenia, 
such as its incorrect association with 
multiple personality disorder.17 Both 
Kraepelin and Bleuler defined the multitude 
of different forms of schizophrenia, with 3 
of Kraepelin’s original definitions still in use 
today: hebephrenic (disorganized), catatonic, 
and paranoid schizophrenia. Little has 
changed in the definition of the disease in 
the last century.17,18 
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Modern treatment and attitudes towards 
schizophrenia 
Early treatments of schizophrenia were 
restricted by a lack of knowledge of the 
brain and an immature understanding of the 
physical and neurochemical aspects of the 
disorder. Therefore, early 20th century 
treatment techniques were often crude and 
under-researched, based primarily on theory 
and lacking solid scientific evidence. 
Treatments for psychosis often involved 
sleep therapy, gas therapy, prefrontal 
leucotomy, and even injecting substances 
such as sulphur or oils into patients to 
induce fever.14,19 In the 1940s, 
electroconvulsive therapy (ECT) was 
developed as a treatment for certain forms 
of schizophrenia and became widespread by 
the 1950s and 1960s. It comprises an electric 
current that is transmitted through the brain 
to induce a seizure, temporarily alleviating 
some of the symptoms of psychotic 
disorders.14 However, a variety of side 
effects and complications from ECT have 
become apparent, ranging from headaches, 
distress and temporary memory loss to more 
severe consequences, such as long-term 
memory loss or changes in personality.14 It is 
the unfavourable side effects of these early 
psychotic treatments, combined with the 
development of antipsychotic drugs and an 
advancement in brain imaging (with the 
invention of computed tomography in 1973 
by Godfrey Hounsfield),20 that has made 
their usage less common over the last 40 
years. 
In the 1950s, the first antipsychotic drug, 
chlorpromazine, was released onto the 
market and rapidly became the primary 
treatment for schizophrenia, making in the 
region of US$75 million in its first year.21 
Chlorpromazine is defined as a first-
generation neuroleptic, as it acts by blocking 
the dopamine D2 receptors in the brain and 
reduces the effects of dopamine secretions, 
theoretically normalizing particular 
neurochemical imbalances.22 In the 1990s, a 
new series of antipsychotics came onto the 
market: second-generation neuroleptics, 
namely risperidone, olanzapine, sertindole, 
and quentiapine.21 These new antipsychotic 
drugs claimed to offer better symptom 
control for patients in the treatment of 
schizophrenia. However, after a series of 
studies, it was revealed that the difference 
between effectiveness of second-generation 
antipsychotics and placebos was marginal, 
with 2 out of the 4 (sertindole and 
quentiapine) shown to be no more effective 
than conventional neuroleptics. One may 
speculate that this disparity could be due to 
competing interests involved in clinical trials 
or perhaps simply real-life factors that are 
difficult to truly replicate in controlled 
environments.21 Second-generation 
antipsychotics act on a variety of dopamine 
receptors, ranging from D1 to D5, and some 
also affect histamine, muscarinic, and 
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serotonin receptors. These neuroleptics 
therefore have much more distinct and 
specific side effects that vary from that of 
conventional drugs.22 Some of the most 
common antipsychotics in use are first-
generation neuroleptics and, like 
chlorpromazine, are mainly derivatives of 
phenothiazine. These are primarily used to 
reduce anxiety and suffering in the patient 
and to lessen the positive symptoms such as 
hallucinations, delusions, and thought 
disjunction characteristic of schizophrenia.22  
The advancement of medical imaging 
techniques has had significant implications 
for the field of psychiatry, by initiating a 
shift in disease models. Schizophrenia 
became viewed as a medically treatable 
disease as the abnormal neuroanatomy of 
schizophrenic patients was highlighted.23 
This was most significant in disbanding 
psychodynamic speculations of the cause of 
schizophrenic symptoms and gave a more 
clinically focused edge to research into 
treatment. Modern theories about the causes 
of schizophrenia mainly revolve around a 
neurochemical imbalance, but psychosis has 
also been attributed to brain oxygen 
deficiency or other biological or anatomical 
causes, similar to that of epilepsy.24 
 
 
Conclusion 
The history of schizophrenia is a history of 
changing attitudes towards mental illness: it 
is the progression from demonic possession 
to identifiable disease, and from exorcisms 
to neuroleptics. The documentation of 
insanity and mental afflictions throughout 
historical texts depicts the development of 
medical knowledge about the brain and its 
constituents, and also shows how the 
illogical and often disconcerting thoughts of 
schizophrenics can have an impact on 
prejudices of mental disease. As this article 
has progressed chronologically through 
periods of history, specifically concerned 
with mental disorder, there has been a 
notable change in public opinion of mental 
conditions, the most significant being in 
recent decades. However, there still remains 
a certain stigma surrounding schizophrenia, 
one that has migrated from associations of 
devilry to implications of violent crime. 
Although treatment methods are now 
available to dampen the positive symptoms 
of schizophrenia, science has yet to develop 
a cure. It is widely believed that 
schizophrenia is a complex disease which 
originates from the interaction between the 
patients’ genes and environment, and future 
research into schizophrenia will continue to 
explore this interaction.   
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Learning Points  
 
What is already known 
• The term “schizophrenia” describes a number of different diseases, presenting with a 
variety of cognitive, perceptual, and behavioural changes. 
• No single cause of the disease has been identified, however, it is thought that both 
genetic and environmental factors are involved. 
• Modern definitions of schizophrenia were significantly influenced by the work of Emil 
Kraepelin and Eugen Bleuler. 
 
What this article adds 
• A speculation into whether historical references of ‘madness’ could be attributed to 
cases of psychosis. 
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